Results 121 to 130 of about 2,862,567 (165)

Integrase Strand Transfer Inhibitors for Treatment-experienced Young Adults With Perinatal HIV in the US: Immunologic, Virologic, and Anthropometric Outcomes. [PDF]

Clin Infect Dis
Patel K, Jaramillo-Underwood A, Karalius B, Yao TJ, Van Dyke RB, Mirza A, Jao J, Agwu AL, Pediatric HIV/AIDS Cohort Study (PHACS).   +8 more
europepmc   +1 more source

Fetal Defects in Mice Treated With Integrase Strand Transfer Inhibitors: Comparison of Dolutegravir, Raltegravir, Bictegravir, and Cabotegravir. [PDF]

J Infect Dis
Mohan H, Nguyen J, Yee A, Laurette EY, Sanghvi T, Tejada O, Jao J, Sled JG, Greene NDE, Copp AJ, Serghides L.   +10 more
europepmc   +1 more source

Recent Developments in the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors Incorporating Pyridine Moiety. [PDF]

Int J Mol Sci, 2023
Starosotnikov AM, Bastrakov MA.
europepmc   +1 more source

Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors. [PDF]

Sci Adv
Hikichi Y, Burdick RC, Patro SC, Ding SY, Luke BT, Clark ED, Ablan SD, Wu X, Pathak VK, Freed EO.   +9 more
europepmc   +1 more source

Differential effects of switching to integrase strand transfer inhibitors on the gut microbiota and markers of HIV disease progression. [PDF]

BMC Microbiol
Pinto-Cardoso SM, Aguilar-Vargas A, López-Filloy M, Chávez-Torres M, Murakami-Osawara A, Briceño O, Romero-Mora K, Rodríguez-Moguel N, Salgado Montes de Oca G, Ávila-Ríos S, MESCAL.   +10 more
europepmc   +1 more source

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023. [PDF]

J Virus Erad
Ferrer P, Ramos V, Durán M, Maureira D, Beltrán C, Afani A.   +5 more
europepmc   +1 more source

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study. [PDF]

EClinicalMedicine
Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Dos Santos Mendes S, Tallada J, Kowalska J, Wallner E, Kusejko K, Jaschinski N, Lundgren J, Peters L, Reekie J.   +23 more
europepmc   +1 more source

Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV. [PDF]

Clin Infect Dis
Abelman RA, Ma Y, Mehta CC, Yang Q, Xia F, Brock JB, Alcaide M, Sharma A, Floris-Moore M, Topper E, Weber KM, Kassaye SG, Gustafson D, Grunfeld C, Lahiri CD, Tien PC.   +15 more
europepmc   +1 more source

Sex differences in discontinuations due to side effects of second-generation integrase strand transfer inhibitors: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Fang Z, Povshedna T, Patterson R, Ready E, Cote HCF, Murray MCM, King EM.   +6 more
europepmc   +1 more source

Pretreatment HIV Drug Resistance to Integrase Strand Transfer Inhibitors Among Newly Diagnosed HIV Individuals - China, 2018-2023. [PDF]

China CDC Wkly
Hu H, Hao J, Wang D, Liu X, Chen H, Li F, Chen J, Li M, Xin P, Li Y, Li Q, Li H, Li J, Hu J, Song C, Feng Y, Liao L, Ruan Y, Xing H.   +18 more
europepmc   +1 more source